Ma et al. also found that miR-34a not only reduced cell proliferation, but also inhibited the tumourigenicity of colon cancer cells by targeting PAR2 (proteinase-activated receptor 2) [29]. This evidence concerns the gene F2RL1 and colonic neoplasm.